Antonio Durando
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
- Oncology 24
- Cancer Treatment and Pharmacology 11
- HER2/EGFR in Cancer Research 8
- Cancer-related Molecular Pathways 3
-
- Breast Cancer Treatment Studies 16
- Co-authors
- Riccardo Arisio (8 shared papers)Dionyssios Katsaros (5 shared papers)Michela Donadio (8 shared papers)Lina Mu (2 shared papers)Mario Preti (2 shared papers)Herbert Yu (2 shared papers)Lingeng Lu (2 shared papers)Biyun Qian (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Breast Cancer Research and Treatment (5 papers)Annals of Oncology (3 papers)Obstetrical & Gynecological Survey (1 paper)The Oncologist (1 paper)
- Partner nations
- ItalyUnited StatesSwitzerland
In The Last Decade
Antonio Durando
41 papers receiving 985 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 440
- Oncology 395
- Pathology and Forensic Medicine 99
- Genetics 110
- Pulmonary and Respiratory Medicine 114
Countries citing papers authored by Antonio Durando
This map shows the geographic impact of Antonio Durando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Durando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Durando more than expected).
Fields of papers citing papers by Antonio Durando
This network shows the impact of papers produced by Antonio Durando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Durando. The network helps show where Antonio Durando may publish in the future.
Co-authors
The 25 scholars most cited alongside Antonio Durando, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 226 | |
| 2 | 2010 | 167 | |
| 3 | 2006 | 102 | |
| 4 | 1981 | 61 | |
| 5 | Metaplastic breast carcinoma: pathology and clinical outcome. | 2003 | 45 |
| 6 | 2004 | 36 | |
| 7 | 2006 | 31 | |
| 8 | 2008 | 26 | |
| 9 | Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy. | 2000 | 25 |
| 10 | 2008 | 23 | |
| 11 | 2013 | 23 | |
| 12 | 2005 | 22 | |
| 13 | 2009 | 19 | |
| 14 | Prognostic factors in metastatic breast cancer patients obtaining objective response or disease stabilization after first-line chemotherapy with epirubicin. Evidence for a positive effect of maintenance hormonal therapy on overall survival. | 1997 | 19 |
| 15 | 2003 | 17 | |
| 16 | 2013 | 16 | |
| 17 | 2001 | 15 | |
| 18 | 2019 | 14 | |
| 19 | 2015 | 13 | |
| 20 | 2007 | 12 |
About Antonio Durando
Antonio Durando is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Pathology and Forensic Medicine, having authored 42 papers that have together received 1.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (16 papers), Cancer Treatment and Pharmacology (11 papers), Advanced Breast Cancer Therapies (8 papers), HER2/EGFR in Cancer Research (8 papers), Cancer-related Molecular Pathways (3 papers), Breast Lesions and Carcinomas (3 papers), Estrogen and related hormone effects (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). The work is most often cited by research in Cancer Research (440 citations), Oncology (395 citations), Pathology and Forensic Medicine (99 citations), Genetics (110 citations) and Pulmonary and Respiratory Medicine (114 citations). Antonio Durando has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Riccardo Arisio, Dionyssios Katsaros, Michela Donadio, Lina Mu, Mario Preti, Herbert Yu, Lingeng Lu, Biyun Qian, Saverio Danese and Anna Sapino. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Annals of Oncology, Obstetrical & Gynecological Survey and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.